|
1.
|
Bosch FX, Manos MM, Munoz N, Sherman M,
Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV:
Prevalence of human papillomavirus in cervical cancer: a worldwide
perspective. International Biological Study on Cervical Cancer
(IBSCC) Study Group. J Natl Cancer Inst. 87:796–802. 1995.
View Article : Google Scholar
|
|
2.
|
Ying J and Lingya P: Role of high-risk
human papillomavirus testing in the screening and management of
cervical cancer precursors. Acta Acade Med Sinic. 29:691–696.
2007.PubMed/NCBI
|
|
3.
|
Zhihong H, Deying Q, Ding W, Danhua H,
Minjian C and Yanhong SH: Study of the relationship between loads
of human papilloma virus in cervical carcinoma and cervical
intraepithelial neoplasia. Matern Child Health Care Chin.
21:1557–1559. 2006.
|
|
4.
|
Shumin L, Wenhua ZH, Lingying W, Fanghui
ZH, Manni H, Nan L and Feng CH: Preliminary study on the
relationship between loads of human papillomavirus in cervical
carcinoma and cervical intraepithelial neoplasia. Chin J Obstet
Gynecol. 39:400–402. 2004.
|
|
5.
|
Fanghui ZH, Junfei M, Youlin Q, Shoude R,
Ling L and Wenhua ZH: Association between high-risk human
papillomavirus DNA load and cervical intraepithelial lesion. Chin J
Epidemiol. 25:921–924. 2004.PubMed/NCBI
|
|
6.
|
Li J, Jinghe L, Youfang W and Xuemei CH:
Relationship of HR-HPV DNA loads with the stages of CIN. Reprod
Contrac. 26:422–425. 2006.
|
|
7.
|
Apgar BS, Zoschnick L and Wright TC Jr:
The 2001 Bethesda System terminology. Am Fam Physician.
68:1992–1998. 2003.
|
|
8.
|
Syrjanen S, Shabalova IP, Petrovichev N,
Kozachenko VP, Zakharova T, Paianidi J, Podistov JI, Chemeris G,
Sozaeva LG, Lipova EV, Tsidaeva I, Ivanchenko OG, Pshepurko AA,
Zakharenko S, Nerovina R, Kljukina LB, Erokhina OA, Branovskaja MF,
Nikitina M, Grunberga V, Grunberg A, Juschenko A, Tosi P, Cintorino
M, Santopietro R and Syrjanen KJ: Human papillomavirus testing and
conventional Pap smear cytology as optional screening tools of
women at different risks for cervical cancer in countries of the
former Soviet Union. J Low Genit Tract Dis. 6:97–110. 2002.
View Article : Google Scholar
|
|
9.
|
Tarkanen J, Auvinen E, Nieminen P, Malmi
R, Vartianen J, Timonen T, Laurila P, Raisanen I, Unnerus HA, Sakki
A, Mattila P, van Den, Brule AV and Tapper AM: HPV DNA testing as
an adjunct in the management of patients with low-grade cytological
lesions in Finland. Acta Obstet Gynecol Scand. 86:367–372. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Ordi J, Alonso I, Torne A, Esteve R,
Sierra E, Campo E and Puiq-Tintore LM: Human papillomavirus load in
Hybrid Capture II assay: does increasing the cutoff improve the
test? Gynecol Oncol. 99:313–319. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Yufei C and Guangze ZH: The roles of
high-risk human papillomavirus detection in cervical cancer
screening. Matern Child Health Care Chin. 21:3434–3436. 2006.
|
|
12.
|
Sherman ME, Lorincz AT, Scott DR,
Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB and
Schiffman M: Baseline cytology, human papillomavirus testing, and
risk for cervical neoplasia: a 10-year cohort analysis. J Natl
Cancer Inst. 95:46–52. 2003.PubMed/NCBI
|
|
13.
|
Cuzick J, Szarewski A, Cubie H, Hulman G,
Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R,
Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C and Sasieni P:
Management of women who test positive for high-risk types of human
papillomavirus: the HART study. Lancet. 362:1871–1876. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Clavel C, Cucherousset J, Lorenzato M,
Caudroy S, Nou JM, Nazeyrollas P, Polette M, Bory JP, Gabriel R,
Ouereux C and Birembaut P: Negative human papillomavirus testing in
normal smears selects a population at low risk for developing
high-grade cervical lesions. Br J Cancer. 90:1803–1808.
2004.PubMed/NCBI
|
|
15.
|
Deying Q, Jianmin C, Ding W, Renhai Z,
Aihua L, Yanhong SH, Danhua H and Zhihong H: Combining high-risk
human papillomavirus DNA test and cytological test to detect early
cervical dysplasia. Chin J Obstet Gynecol. 41:34–37.
2006.PubMed/NCBI
|
|
16.
|
Munoz N, Bosch FX, Sanjose SDE, Herrero R,
Castellsaque X, Shah KV, Snijder PJ and Meijer CJ; the
International Agency for Research on Cancer Multicenter Cervical
Cancer Study Group: Epidemiologic classification of human
papillomavirus types associated with cervical cancer. N Engl J Med.
348:518–527. 2003. View Article : Google Scholar : PubMed/NCBI
|
